# XCel Brands, Inc.: overview XELB · Nasdaq · CIK 1083220 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/xelb.md) · [Financials](/companies/xelb/financials.md) · [Filings](/companies/xelb/filings.md) · [Insiders](/companies/xelb/insiders.md) Latest reported revenue: [$1.1m](/filings/0001104659-26-096016.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001104659-26-096016). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,912](/filings/0001104659-25-114198.md) | [1,209 d](/filings/0001104659-26-043348.md) | [1,332](/filings/0001104659-26-061185.md) | [1,321](/filings/0001104659-26-096016.md) | [1,118](/filings/0001104659-25-114198.md) | [1,168 d](/filings/0001104659-26-043348.md) | [1,144](/filings/0001104659-26-061185.md) | [1,121](/filings/0001104659-26-096016.md) | | Gross margin | % | [78.7%](/filings/0001104659-25-114198.md) | [100.0% d](/filings/0001104659-26-043348.md) | not reported | [100.0%](/filings/0001558370-25-011582.md) | [100.0%](/filings/0001104659-25-114198.md) | [100.0% d](/filings/0001104659-26-043348.md) | not reported | not reported | | Operating margin | % | [(474.8%)](/filings/0001104659-25-114198.md) | [(532.9%) d](/filings/0001104659-26-043348.md) | [(164.2%)](/filings/0001104659-26-061185.md) | [(125.2%)](/filings/0001104659-26-096016.md) | [(665.7%)](/filings/0001104659-25-114198.md) | [(166.8%) d](/filings/0001104659-26-043348.md) | [(164.7%)](/filings/0001104659-26-061185.md) | [(141.4%)](/filings/0001104659-26-096016.md) | | Net margin | % | [(481.9%)](/filings/0001104659-25-114198.md) | [(585.9%) d](/filings/0001104659-26-043348.md) | [(210.0%)](/filings/0001104659-26-061185.md) | [(301.9%)](/filings/0001104659-26-096016.md) | [(706.5%)](/filings/0001104659-25-114198.md) | [(237.8%) d](/filings/0001104659-26-043348.md) | [(217.6%)](/filings/0001104659-26-061185.md) | [(220.9%)](/filings/0001104659-26-096016.md) | | Diluted EPS | $ per share | [(3.92)](/filings/0001104659-25-114198.md) | not reported | [(1.18)](/filings/0001104659-26-061185.md) | [(1.66)](/filings/0001104659-26-096016.md) | [(2.02)](/filings/0001104659-25-114198.md) | not reported | [(0.42)](/filings/0001104659-26-061185.md) | [(0.40)](/filings/0001104659-26-096016.md) | | Free cash flow | $k | [(432) d](/filings/0001104659-25-114198.md) | [(1,409) d](/filings/0001104659-26-043348.md) | [(1,448)](/filings/0001104659-26-061185.md) | [(2,368) d](/filings/0001104659-26-096016.md) | [(1,398) d](/filings/0001104659-25-114198.md) | [(1,827) d](/filings/0001104659-26-043348.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [37.9](/filings/0001558370-23-006076.md) | [25.8](/filings/0001558370-24-005326.md) | [17.8](/filings/0001558370-25-008172.md) | [8.3](/filings/0001104659-26-043348.md) | [4.9](/filings/0001104659-26-043348.md) | | Gross margin | % | [71.9%](/filings/0001558370-23-006076.md) | [69.0%](/filings/0001558370-24-005326.md) | [61.0%](/filings/0001558370-25-008172.md) | [94.6%](/filings/0001104659-26-043348.md) | [100.0%](/filings/0001104659-26-043348.md) | | Operating margin | % | [(33.1%)](/filings/0001558370-23-006076.md) | [(8.8%)](/filings/0001558370-24-005326.md) | [(116.3%)](/filings/0001558370-25-008172.md) | [(259.2%)](/filings/0001104659-26-043348.md) | [(267.9%)](/filings/0001104659-26-043348.md) | | Net margin | % | [(32.1%)](/filings/0001558370-23-006076.md) | [(15.6%)](/filings/0001558370-24-005326.md) | [(118.6%)](/filings/0001558370-25-008172.md) | [(271.2%)](/filings/0001104659-26-043348.md) | [(353.5%)](/filings/0001104659-26-043348.md) | | Diluted EPS | $ per share | [(0.63)](/filings/0001558370-23-006076.md) | [(0.20)](/filings/0001558370-24-005326.md) | [(10.68)](/filings/0001558370-25-008172.md) | [(9.84)](/filings/0001104659-26-043348.md) | [(5.08)](/filings/0001104659-26-043348.md) | | Free cash flow | $m | [(7.7)](/filings/0001558370-23-006076.md) | [(14.4)](/filings/0001558370-24-005326.md) | [(6.6)](/filings/0001558370-25-008172.md) | [(4.8)](/filings/0001104659-26-043348.md) | [(7.0)](/filings/0001104659-26-043348.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xelb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Summit Trail Advisors, LLC](/funds/1698478.md) | 2026-06-30 | $596.6k | 331,436 | | Unchanged | | [Potomac Capital Management, Inc.](/funds/1418746.md) | 2026-06-30 | $450.1k | 250,058 | | Reduced −158,342 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $86.9k | 48,293 | | Added +4,780 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $50.1k | 27,817 | | Reduced −30,052 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $50.0k | 27,759 | | Added +19,983 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $49.3k | 27,400 | | New +27,400 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $29.7k | 16,518 | | Reduced −587 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $21.6k | 11,985 | | New +11,985 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $18.0k | 10,000 | | Unchanged | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $3.0k | 1,675 | | Added +1,197 | ## Recent filings [All 749 filings](/companies/xelb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-02 | 20:55 ET | [8-K](/filings/0001104659-26-113338.md) | 3.01 Delisting notice | 0001104659-26-113338 | | 2026-08-19 | 20:30 ET | [8-K](/filings/0001104659-26-098791.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-098791 | | 2026-08-13 | 20:53 ET | [10-Q](/filings/0001104659-26-096016.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096016 | | 2026-08-06 | 23:18 ET | [10-K/A](/filings/0001104659-26-091375.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-091375 | | 2026-06-23 | 21:01 ET | [8-K](/filings/0001104659-26-076855.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-076855 | | 2026-05-26 | 22:49 ET | [8-K](/filings/0001104659-26-065835.md) | 8.01 Other events | 0001104659-26-065835 | | 2026-05-14 | 20:15 ET | [10-Q](/filings/0001104659-26-061185.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061185 | | 2026-04-30 | 20:47 ET | [8-K](/filings/0001104659-26-053074.md) | 1.01 Entry into a material agreement | 0001104659-26-053074 | | 2026-04-24 | 21:45 ET | [S-1/A](/filings/0001104659-26-047895.md) | Registration statement, amended | 0001104659-26-047895 | | 2026-04-17 | 20:45 ET | [8-K](/filings/0001104659-26-044940.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-044940 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-043348.md), filed Apr 15, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/cd34f2d2-f498-4a66-89fc-c4cf502d04df) ## About the filer - CIK: 1083220 - Tickers: XELB - Exchange: Nasdaq - SIC code: 6794 Patent Owners & Lessors - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.